Changes in intraocular pressure and tear secretion in patients given 5  mg solifenacin for the treatment of overactive bladder

ConclusionsSolifenacin succinate is useful in eliminating OAB symptoms in female patients, but can cause systemic side effects. It had no significant side effects on tear secretion (Schirmer I) and IOP. We concluded that solifenacin succinate could be reliably used in pure OAB patients without comorbidity in terms of dry eye and IOP. We believe that prospective studies with larger series are still needed to reach a definite conclusion.
Source: International Urogynecology Journal and Pelvic Floor Dysfunction - Category: OBGYN Source Type: research